These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3709641)
1. PY 108-068--acute effects of a single oral dose in chronic stable angina. de Buitleir M; Krikler S; Krikler DM Eur J Clin Pharmacol; 1986; 30(2):167-70. PubMed ID: 3709641 [TBL] [Abstract][Full Text] [Related]
2. Objective evaluation of PY-108-068, a new calcium channel inhibitor for the treatment of chronic stable angina pectoris. O'Hara MJ; Khurmi NS; Bowles MJ; Raftery EB Eur Heart J; 1985 Aug; 6(8):689-94. PubMed ID: 4054138 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of PY 108-068, a new calcium channel blocker, for angina pectoris. de Buitleir M; Krikler S; Krikler DM Am J Cardiol; 1986 Jan; 57(1):15-9. PubMed ID: 3079940 [TBL] [Abstract][Full Text] [Related]
4. Short- and long-term efficacy of nicardipine, assessed by placebo-controlled single- and double-blind crossover trials in patients with chronic stable angina. Khurmi NS; Bowles MJ; Bala Subramanian V; Raftery EB J Am Coll Cardiol; 1984 Nov; 4(5):908-17. PubMed ID: 6386933 [TBL] [Abstract][Full Text] [Related]
5. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group. Frishman WH; Pepine CJ; Weiss RJ; Baiker WM J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428 [TBL] [Abstract][Full Text] [Related]
6. Randomized double-blind placebo-controlled comparison of nicardipine and nifedipine in patients with chronic stable angina pectoris. Bowles MJ; Khurmi NS; O'Hara MJ; Raftery EB Chest; 1986 Feb; 89(2):260-5. PubMed ID: 3510823 [TBL] [Abstract][Full Text] [Related]
7. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects. Lam J; Chaitman BR; Crean P; Blum R; Waters DD J Am Coll Cardiol; 1985 Aug; 6(2):447-52. PubMed ID: 3894474 [TBL] [Abstract][Full Text] [Related]
8. Lack of negative inotropic effects of the new calcium antagonist Ro 40-5967 in patients with stable angina pectoris. Portegies MC; Schmitt R; Kraaij CJ; Braat SH; Gassner A; Hagemeijer F; Pozenel H; Prager G; Viersma JW; van der Wall EE J Cardiovasc Pharmacol; 1991 Nov; 18(5):746-51. PubMed ID: 1723772 [TBL] [Abstract][Full Text] [Related]
9. Comparative antianginal effects of nisoldipine and nifedipine in patients with chronic stable angina. Crean PA; Waters DD; Lam J; Chaitman BR Am Heart J; 1987 Feb; 113(2 Pt 1):261-5. PubMed ID: 3544754 [TBL] [Abstract][Full Text] [Related]
10. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease. Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794 [TBL] [Abstract][Full Text] [Related]
12. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial. Ruzyllo W; Tendera M; Ford I; Fox KM Drugs; 2007; 67(3):393-405. PubMed ID: 17335297 [TBL] [Abstract][Full Text] [Related]
13. Improvement in exercise performance with nisoldipine, a new second-generation calcium blocker, in stable angina patients. Lopez LM; Rubin MR; Holland JP; Mehta JL Am Heart J; 1985 Nov; 110(5):991-6. PubMed ID: 3933316 [TBL] [Abstract][Full Text] [Related]
14. Clinical safety and efficacy of once-a-day amlodipine for chronic stable angina pectoris. Glasser SP; West TW Am J Cardiol; 1988 Sep; 62(9):518-22. PubMed ID: 2970788 [TBL] [Abstract][Full Text] [Related]
15. Ambulatory monitoring and exercise testing in the evaluation of a new long-acting calcium ion antagonist KB-944 (Fostedil) for the treatment of exertional angina pectoris. Khurmi NS; Bowles MJ; O'Hara MJ; Lahiri A; Raftery EB Int J Cardiol; 1985 Nov; 9(3):289-302. PubMed ID: 3902675 [TBL] [Abstract][Full Text] [Related]
16. Effects of bepridil on exercise tolerance in chronic stable angina: a double-blind, randomized, placebo-controlled, crossover trial. Hill JA; O'Brien JT; Scott E; Conti CR; Pepine CJ Am J Cardiol; 1984 Mar; 53(6):679-83. PubMed ID: 6367414 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the International Multicenter Angina Exercise (IMAGE) Study. Savonitto S; Ardissiono D; Egstrup K; Rasmussen K; Bae EA; Omland T; Schjelderup-Mathiesen PM; Marraccini P; Wahlqvist I; Merlini PA; Rehnqvist N J Am Coll Cardiol; 1996 Feb; 27(2):311-6. PubMed ID: 8557899 [TBL] [Abstract][Full Text] [Related]
18. Interim report of multicenter double-blind, placebo-controlled studies of nifedipine in chronic stable angina. Mueller HS; Chahine RA Am J Med; 1981 Oct; 71(4):645-57. PubMed ID: 6792916 [TBL] [Abstract][Full Text] [Related]
19. [Acute effects of propranolol and its association with nifedipine in aged patients with effort stable angina. Randomized double-blind crossover study, under placebo control]. Santamaria F; Sestito M; Lirato C; Di Palma A; De Rosa ML; Iannuzzi L; Pandolfi E; Cicatiello AM; Parlati S Minerva Cardioangiol; 1993 Apr; 41(4):139-45. PubMed ID: 8332270 [TBL] [Abstract][Full Text] [Related]
20. [Anti-angina effect of gallopamil in comparison with another calcium antagonist and a placebo]. Hopf R; Drews H; Kaltenbach M Z Kardiol; 1984 Sep; 73(9):578-85. PubMed ID: 6391005 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]